CSL Ltd.

CSL Ltd. is a global biotechnology firm known for its development, manufacture, and marketing of innovative biotherapies and influenza-related products. It primarily operates in two segments: CSL Behring, which focuses on innovative medicines for patients suffering from serious and rare diseases, and Seqirus, one of the largest influenza vaccine companies in the world. CSL is involved in producing plasma-derived therapies, vaccines, and recombinant technologies, catering to needs in immunology, neurology, and hematology. The company's cutting-edge research and development divisions contribute significantly to advancing health solutions. Headquartered in Melbourne, Australia, CSL plays a pivotal role in the healthcare industry by supplying critical therapies across diverse markets. Through its continuous commitment to innovation and quality, CSL Ltd. has established itself as a key player in enhancing patient lives worldwide, maintaining significant influence in both emerging and established pharmaceutical markets.